Range Low Price High Price Comment
30 days $11.90 $18.12 Tuesday, 30th Apr 2024 NRIX stock ended at $12.02. This is 3.61% less than the trading day before Monday, 29th Apr 2024. During the day the stock fluctuated 4.87% from a day low at $11.90 to a day high of $12.48.
90 days $7.79 $18.12
52 weeks $4.22 $18.12

Historical Nurix Therapeutics, Inc. prices

Date Open High Low Close Volume
Apr 30, 2024 $12.25 $12.48 $11.90 $12.02 767 302
Apr 29, 2024 $12.98 $12.98 $12.37 $12.47 801 807
Apr 26, 2024 $12.49 $12.60 $12.18 $12.36 599 462
Apr 25, 2024 $13.29 $13.34 $12.27 $12.36 942 879
Apr 24, 2024 $14.05 $14.42 $13.52 $13.75 519 360
Apr 23, 2024 $13.59 $14.44 $13.59 $14.13 681 923
Apr 22, 2024 $13.69 $14.09 $13.30 $13.58 574 461
Apr 19, 2024 $14.33 $14.84 $12.95 $13.59 1 017 261
Apr 18, 2024 $14.11 $14.60 $13.64 $14.44 972 955
Apr 17, 2024 $15.10 $15.22 $13.90 $14.08 946 591
Apr 16, 2024 $15.40 $15.40 $14.39 $14.65 1 076 709
Apr 15, 2024 $16.71 $16.71 $15.44 $15.46 2 473 259
Apr 12, 2024 $16.45 $16.81 $15.43 $16.74 3 874 275
Apr 11, 2024 $17.09 $18.12 $16.36 $17.21 1 034 789
Apr 10, 2024 $16.67 $17.00 $15.46 $15.69 1 734 637
Apr 09, 2024 $13.95 $17.51 $13.81 $17.48 1 727 431
Apr 08, 2024 $14.12 $14.12 $13.46 $13.80 445 523
Apr 05, 2024 $14.14 $14.15 $13.51 $13.90 416 701
Apr 04, 2024 $14.75 $15.19 $13.80 $13.94 821 492
Apr 03, 2024 $14.67 $14.77 $13.82 $14.59 621 289
Apr 02, 2024 $14.21 $15.12 $13.98 $14.86 742 882
Apr 01, 2024 $14.59 $15.28 $14.13 $14.58 723 197
Mar 28, 2024 $14.54 $15.33 $14.18 $14.70 1 311 309
Mar 27, 2024 $13.19 $14.61 $12.55 $14.54 1 331 968
Mar 26, 2024 $13.81 $14.03 $12.91 $13.02 657 727
Click to get the best stock tips daily for free!

About Nurix Therapeutics, Inc.

Nurix Therapeutics. Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies; NX-5948, an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malig... NRIX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT